Among the changes, oncogenes such as ADAM19, EPHA3, and KLF4 showed increased expression, but tumor suppressors like CDKN2A and BRCA2 demonstrated decreased expression by inhibition of METTL3- or METTL14. The gene discussed is METTL3; the disease is neoplasm.